
Saturday, January 21, 2023 12:58:24 PM
Little wonder the FHFA never wants the 14+ year CONservatorships to end, and they could easily keep 100% control over the GSES by keeping them in perpetual conservatorships and continually bypassing the Congressional Appropriations Oversight Process for their operating funds as well as have the GSES balance sheets bankroll the expensive legal defenses of the perpetual conservatorships.
Amerika, my kinda place

I thought someone was going to come in and clean up the swamp, because apparently this arrangement is "a okay" with the federal courts.

Liked By
Spread the love. Be the first to like this post!
Recent FNMA News
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/14/2023 12:27:31 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 04:31:58 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 04:31:28 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 04:22:27 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 04:21:06 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 04:17:16 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 04:01:39 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:59:22 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:56:03 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:49:15 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:39:16 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:32:23 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:30:30 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:23:43 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:15:26 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 03:09:21 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:54:56 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:48:45 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:44:05 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:34:01 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:33:23 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:27:05 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:13:11 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:11:51 PM
- Amended Disclosure of Asset-backed Securities (abs-15g/a) • Edgar (US Regulatory) • 02/13/2023 02:04:46 PM
FEATURED Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • Mar 31, 2023 7:07 AM
ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM
Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM
ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM
Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM
OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM